Don’t forget to nominate the fiercest women in life sciences

Three people looking at a display of black and white photos depecting a diverse group of people
Your nominees may be industry professionals, academics, venture capitalists—you name it. If she's making a mark on the life sciences industry, we want to hear about her. (Gerd Altmann)

If your nominations for this year’s Fiercest Women in Life Sciences have been on the back burner lately, now is the perfect time to submit them. Nominations will close next Monday, Aug. 13.

Just to recap, we're looking for women in biotech, pharma and medtech who, in spite of challenges both unique to the industry and to being female, stand out as leaders, innovators and mentors. They can be industry professionals, academics, venture capitalists—you name it.

We're often asked whether we have a list of criteria for consideration. We don't. If a particular woman is making a mark on the life sciences industry, we want to hear about her.

For a taste of what we’re looking for, check out last year's feature here and 2016’s here. Please submit your nominations using the form below.

 

Free Daily Newsletter

Like this story? Subscribe to FiercePharma!

Biopharma is a fast-growing world where big ideas come along daily. Our subscribers rely on FiercePharma as their must-read source for the latest news, analysis and data on drugs and the companies that make them. Sign up today to get pharma news and updates delivered to your inbox and read on the go.

Suggested Articles

An injection that's under FDA priority review as a monthly HIV therapy can suppress the virus even if given every two months, a phase 3 has shown.

Pfizer and Astellas are chasing a new nod for prostate cancer drug Xtandi, and thanks to the FDA, they might not have to wait that long.

Sanofi lost an appeal challenging the ban on its dengue vaccine Dengvaxia in the Philippines, despite an ongoing outbreak there.